Your browser doesn't support javascript.
Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System database.
Abdel-Rahman, Omar.
  • Abdel-Rahman O; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada.
Future Oncol ; 17(36): 5045-5051, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1496871
ABSTRACT

Aim:

To explore factors affecting coronavirus disease 2019 (COVID-19) mortality among cancer patients based on a pharmacovigilance database.

Methods:

US FDA Adverse Event Reporting System (FAERS) quarterly data extract files were reviewed for quarters two, three and four of 2020 (i.e., April to December). Patients with an indication related to malignancy and a reported COVID-related reaction were selected. Multivariate logistic regression analysis for factors associated with a fatal outcome was conducted.

Results:

A total of 2708 patients were included. The following factors were associated with fatal COVID-19 infection older age (odds ratio [OR] 1.03; 95% CI 1.01-1.04), male sex (OR 1.43; 95% CI 1.07-1.91), non-US report source (OR 2.46; 95% CI 1.93-3.13), hematological malignancy (OR 1.62; 95% CI 1.28-2.07), potentially immunosuppressive treatment (OR 1.83; 95% CI 1.30-2.58) and diagnosis in quarter two versus quarter four (OR 1.62; 95% CI 1.27-2.07).

Conclusion:

Within FAERS reports, cancer patients who are older, males and receiving immunosuppressive treatment and those with hematological malignancies were at a higher risk of death because of COVID-19 infection.
Lay abstract In this study, individuals with a diagnosis of cancer who were older and males and those receiving immunosuppressive treatment seemed to be at a higher risk of a fatal outcome of coronavirus disease 2019 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Future Oncol Year: 2021 Document Type: Article Affiliation country: Fon-2021-0816

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Future Oncol Year: 2021 Document Type: Article Affiliation country: Fon-2021-0816